Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

June 5, 2024 | Poster
Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC).
ASCO
May 3, 2024 | Blog Post
MRD Testing: Finding Common Ground
February 29, 2024 | Article
Toward a cure for cHL without chemotherapy
Blood
February 6, 2024 | Video
Early and sustained ctDNA response in lonca for 3L DLBCL – Dr. David Kurtz, ASH 2023
ASH
January 31, 2024 | Video
Prospective real-world study on the utility of PhasED-Seq MRD – Dr. Brian Sworder, ASH 2023
ASH
January 31, 2024 | Video
Optimizing ctDNA limits of detection for DLBCL during 1L therapy – Dr. Jordan Goldstein, ASH 2023
ASH